Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine and A2A Receptors in Human Brown Adipose Tissue
NCT03327168Completed
- Sponsor
- Turku University Hospital
- Start
- Nov 2015
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Open-label trial of adenosine in obesity (3 arms), sponsored by Turku University Hospital. Primary endpoints: Brown Adipose Tissue Perfusion at 10 minutes and Adenosine A2A Receptor Density in BAT at 3 hours. Started Nov 2015; status: completed.
02
Drugs
adenosine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03327168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03327168.